Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 20% Azelaic Acid Versus 4% Hydroquinone in Epidermal Melasma
NCT07327983Completed
- Sponsor
- Gujranwala Medical College District Headquarters Hospital
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of azelaic acid 15% gel vehicle in melasma (2 arms), sponsored by Gujranwala Medical College District Headquarters Hospital. Primary endpoint: Melasma Area and Severity Index at 12 weeks. Started May 2025; status: completed.
02
Drugs
azelaic acid 15% gel vehicle
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07327983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07327983.